GMED (Globus Medical) Total Liabilities: $707 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GMED Globus Medical Inc GMED
97 GF Score
Price $79.75
GF Value $98.75
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Globus Medical Total Liabilities?

Globus Medical GMED +2.10% 97 Total Liabilities is $707 Mil as of Mar. 2026. GuruFocus rates GMED with a GF Score™ of 97/100 and a GF Value™ of $98.75 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Globus Medical's Total Liabilities for the quarter that ended in Mar. 2026 was $707 Mil.

Globus Medical's quarterly Total Liabilities increased from Sep. 2025 ($696.82 Mil) to Dec. 2025 ($729.51 Mil) but then declined from Dec. 2025 ($729.51 Mil) to Mar. 2026 ($707.24 Mil).

Globus Medical's annual Total Liabilities declined from Dec. 2023 ($1,088.12 Mil) to Dec. 2024 ($1,074.42 Mil) and declined from Dec. 2024 ($1,074.42 Mil) to Dec. 2025 ($729.51 Mil).

Globus Medical Total Liabilities Historical Data

* Premium members only.

The historical data trend for Globus Medical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globus Medical Total Liabilities Chart

Globus Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 215.88 229.75 1,088.12 1,074.42 729.51

Globus Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 623.08 665.41 696.82 729.51 707.24
GMED
97GF Score
Globus Medical Inc GMED
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Globus Medical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Globus Medical's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=498.499+(103.918+103.338
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+23.756+0+0)
=730

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=5302.761-4573.25
=730

Globus Medical's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=482.463+(100.102+100.02
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+24.658+0+0)
=707

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=5439.555-4732.312
=707

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $707 Mil mean?
Globus Medical (GMED) has a Total Liabilities of $707 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Globus Medical and its competitors.
Is Globus Medical's Total Liabilities too high?
Globus Medical's current Total Liabilities is $707 Mil. Overall, Globus Medical has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Total Liabilities compare to PEN and PODD?
Globus Medical's Total Liabilities of $707 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Globus Medical and its competitors. Globus Medical's current Total Liabilities is $707 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is $98.75, compared to a current price of $79.75 — trading 19.2% below its estimated fair value. The current Total Liabilities is $707 Mil. Globus Medical's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Globus Medical (GMED), the current Total Liabilities is $707 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Globus Medical (GMED) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of $79.75 is trading 19.2% below its estimated GF Value™ of $98.75. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for GMED:

  • Total Liabilities: $707 Mil
  • GF Value™: $98.75 vs. price of $79.75 (19.2% below fair value)
  • GF Score™: 97/100 with 4 warning signs

No single metric tells the full story. See the GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Globus Medical Business Description

Other Exchanges GMED:MexicoGM0N:Germany
Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
97GF Score

Get the complete analysis for GMED

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$79.75
Price
$98.75
GF Value